EA
46
-3
TXT
72
-3
MNST
61
-2
AMGN
44
-3
SBUX
35
2
JPM
66
2
DG
28
-6
CME
37
3
PFE
32
2
UAL
50
6
FSLR
47
-11
CB
50
-4
MET
58
-2
GOOG
87
-2
AA
38
4
BRK.B
34
-2
COF
64
5
URBN
50
-12
CMG
34
3
AEP
59
-3
EA
46
-3
TXT
72
-3
MNST
61
-2
AMGN
44
-3
SBUX
35
2
JPM
66
2
DG
28
-6
CME
37
3
PFE
32
2
UAL
50
6
FSLR
47
-11
CB
50
-4
MET
58
-2
GOOG
87
-2
AA
38
4
BRK.B
34
-2
COF
64
5
URBN
50
-12
CMG
34
3
AEP
59
-3
Financhill
Back

MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
21

FNGD
MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN

Last Price:
24.71
Seasonality Move:
-8.29%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
157.93
Seasonality Move:
18.65%
Sell
21
MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN (FNGD) is a Sell

Is MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN a Buy, Sell or Hold?

  • The current MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN [FNGD] share price is $24.65. The Score for FNGD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • FNGD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $157.74. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FNGD Stock Price Chart

What is MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN's stock price today?

  • The MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN share price today is $24.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FNGD is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $157.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.

FNGD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.07 Sell
Relative Strength Index (14 RSI): 34.68 Sell
Chaikin Money Flow: 2164975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.31 - 30.97) Sell
Bollinger Bands (100): (30.07 - 40.13) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.67 Buy
Relative Strength Index (14 RSI): 68.69 Buy
Chaikin Money Flow: -86202 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (114.06 - 147.06) Buy
Bollinger Bands (100): (118.53 - 137.75) Buy

FNGD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.27 Sell
20-day SMA: 27.46 Sell
50-day SMA: 32.17 Sell
200-day SMA: 54.77 Sell
8-day EMA: 25.33 Sell
20-day EMA: 27.12 Sell
50-day EMA: 30.97 Sell
200-day EMA: 68.44 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 149.53 Buy
20-day SMA: 132.97 Buy
50-day SMA: 129.56 Buy
200-day SMA: 115.84 Buy
8-day EMA: 150.26 Buy
20-day EMA: 138.97 Buy
50-day EMA: 131.58 Buy
200-day EMA: 121.41 Buy

MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN Earnings Growth & FNGD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.

MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):